Novel insights into P450 BM3 interactions with FDA-approved antifungal azole drugs. (2019)
Attributed to:
Molecular reconstruction of flavocytochrome P450 BM3
funded by
BBSRC
Abstract
No abstract provided
Bibliographic Information
Digital Object Identifier: http://dx.doi.org/10.1038/s41598-018-37330-y
PubMed Identifier: 30733479
Publication URI: http://europepmc.org/abstract/MED/30733479
Type: Journal Article/Review
Volume: 9
Parent Publication: Scientific reports
Issue: 1
ISSN: 2045-2322